Loading clinical trials...
Loading clinical trials...
An Open-Label, Randomized, Single Application, Two-Period Crossover, Pivotal Bioequivalence Study to Evaluate the Bioequivalence of Fentanyl Transdermal System (JNJ-35685-AAA-G021) Compared With DURAGESIC Fentanyl Transdermal Patch in Healthy Subjects
Conditions
Interventions
Fentanyl
Fentanyl
Locations
1
United States
Cypress, California, United States
Start Date
November 1, 2015
Primary Completion Date
June 1, 2016
Completion Date
June 1, 2016
Last Updated
February 3, 2025
NCT06290258
NCT00090662
NCT07310264
NCT06716502
NCT07483606
NCT06342713
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions